Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Biscetti

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Mechanisms of Ageing and Development|May 2, 2022
Sortilin/Omentin-1 ratio in peripheral artery disease: A cross-sectional study on 295 unselected elderly patientsSilvia Giovannini, Federico Biscetti, Fabrizio Brau, et al.
International Journal of Molecular Sciences|December 15, 2019
High Mobility Group Box-1 and Diabetes Mellitus Complications: State of the Art and Future PerspectivesFederico Biscetti, Maria Margherita Rando, Elisabetta Nardella, et al.
Geroscience|April 9, 2025
Association of Klotho and FGF23 with cardiovascular outcomes in diabetic older adults with chronic limb-threatening ischemia: a prospective studyFederico Biscetti, Silvia Giovannini, Roberto Iezzi, et al.
Molecular and Cellular Endocrinology|July 30, 2013
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγFederico Biscetti, Giovanni Pecorini, Vincenzo Arena, et al.
Medicine|December 1, 2016
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU)Federico Biscetti, Angela Carbonella, Federico Parisi, et al.
Cardiovascular Diabetology|August 10, 2017
Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjectsSilvia Giovannini, Giovanni Tinelli, Federico Biscetti, et al.
Scientific Reports|March 20, 2026
Prevalence of alcohol use disorder and its association with disease severity in symptomatic peripheral arterial diseaseFederico Biscetti, Maria Margherita Rando, Martina Danese, et al.
Cardiovascular Diabetology|June 7, 2019
Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery diseaseFederico Biscetti, Elisabetta Nardella, Nicola Bonadia, et al.
International Journal of Cardiology|April 5, 2012
Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanismFederico Biscetti, Giovanni Pecorini, Giuseppe Straface, et al.
Cardiovascular Diabetology|January 13, 2019
Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjectsFederico Biscetti, Nicola Bonadia, Francesco Santini, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Mechanisms of Ageing and Development|May 2, 2022
Sortilin/Omentin-1 ratio in peripheral artery disease: A cross-sectional study on 295 unselected elderly patientsSilvia Giovannini, Federico Biscetti, Fabrizio Brau, et al.
International Journal of Molecular Sciences|December 15, 2019
High Mobility Group Box-1 and Diabetes Mellitus Complications: State of the Art and Future PerspectivesFederico Biscetti, Maria Margherita Rando, Elisabetta Nardella, et al.
Geroscience|April 9, 2025
Association of Klotho and FGF23 with cardiovascular outcomes in diabetic older adults with chronic limb-threatening ischemia: a prospective studyFederico Biscetti, Silvia Giovannini, Roberto Iezzi, et al.
Molecular and Cellular Endocrinology|July 30, 2013
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγFederico Biscetti, Giovanni Pecorini, Vincenzo Arena, et al.
Medicine|December 1, 2016
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU)Federico Biscetti, Angela Carbonella, Federico Parisi, et al.
Cardiovascular Diabetology|August 10, 2017
Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjectsSilvia Giovannini, Giovanni Tinelli, Federico Biscetti, et al.
Scientific Reports|March 20, 2026
Prevalence of alcohol use disorder and its association with disease severity in symptomatic peripheral arterial diseaseFederico Biscetti, Maria Margherita Rando, Martina Danese, et al.
Cardiovascular Diabetology|June 7, 2019
Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery diseaseFederico Biscetti, Elisabetta Nardella, Nicola Bonadia, et al.
International Journal of Cardiology|April 5, 2012
Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanismFederico Biscetti, Giovanni Pecorini, Giuseppe Straface, et al.
Cardiovascular Diabetology|January 13, 2019
Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjectsFederico Biscetti, Nicola Bonadia, Francesco Santini, et al.
Pageof 7